Global Nasal Drug Delivery Market: Industry Analysis and Forecast


Posted August 19, 2020 by mmrseo4

Global Nasal Drug Delivery Market was valued US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a CAGR of 6.9% during a forecast period.
 
Global Nasal Drug Delivery Market was valued US$ XX Bn in 2019 and is expected to reach US$ XX Bn by 2027, at a CAGR of 6.9% during a forecast period.

Global Nasal Drug Delivery Market, By Container

Market Definition

The rising incidence of chronic diseases is also projected to contribute to marketplace expansion over the coming years. The non-pressurized packing containers segment is likely to grow at a CAGR of XX% during the estimated period. North America is probable to dominate the global nasal drug delivery market during the forecast duration. Moreover, the well-developed healthcare region and the presence of a big variety of medical device companies in this region increase marketplace growth.The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Market Dynamics

The use of the nasal route for the delivery of hard drugs inclusive of small polar molecules, vaccines, hormones, peptides, and proteins has created tons hobby in recent times. Owing to the excessive permeability, high vasculature, the low enzymatic environment of the nasal cavity and avoidance of hepatic first pass metabolism are properly suitable for systemic shipping of drug molecule through the nostril. Many drug delivery devices for nasal utility of liquid, semisolid and stable formulation are investigated to deliver the drugs to the treatment of most crisis CNS illnesses (i.e., Parkinson’s disease, Alzheimer’s disorder) because it requires speedy and/or specific focused on of drugs to the mind.

The developing incidence of chronic diseases is also anticipated to contribute to marketplace expansion over the coming years. Rising patient preference for nasal drug delivery as a result of easy management & higher efficiency and developing adoption of self-administration practices are a number of the primary factors driving the growth of the nasal drug delivery technology market. Besides, growth amongst over the counter nasal drugs and growing attention on alternative routes of drug transport together with nasal drug delivery provide sizable boom possibilities for players working within the marketplace. Intranasal drug transport is one of the most desired drugs this will majorly be attributed to the non-invasive nature of this route of delivery and the reality that drug absorbability is higher through the nasal route.

Delivery routes between patients in addition to healthcare carriers. In addition, the nasal path gives less antagonistic surroundings in comparison to the gastro-intestinal course; this permits higher absorption of drugs. Considering those factors, the inclination for nasal drug delivery is growing amongst patients in addition to healthcare carriers. Furthermore, the commercialization of novel products and the presence of strong product pipeline are expected to reinforce the marketplace growth. For instance, Eli Lilly and Company developed a healing spray (intranasal glucagon) for the remedy of low blood sugar. According to the Global Asthma Report 2018, published via Global Asthma Network, around 330 million people suffer from asthma. Moreover, nasal drug delivery systems offer benefits, inclusive of noninvasiveness and reduction in lag-time precipitated due to oral drug delivery. These advantages help in providing better patient comfort, which in turn, improves their adherence to medicine. According to a study led via Binghamton University, State University at New York, in August 2018, Narcan (naloxone), a single-step nasal spray, is the very best product to deliver.
However, complications associated with the overuse of nasal sprays may additionally restraint the growth of the market.

Global Nasal Drug Delivery Market Segment analysis

Based on the container, the non-pressurized packing containers segment is projected to grow at a CAGR of XX% during the forecast length. The nasal drug delivery generation marketplace is segmented into pressurized and non-pressurized packing containers. In 2019, the non-pressurized containers segment is anticipated to account for the most important percentage of the marketplace. This may be in most cases attributed to advantages which include higher versatility and reliability, immediate accessibility, self-containment, better portability, and coffee-value scientific aerosol delivery. Furthermore, the growing utilization of those devices for the remedy of reversible airflow obstruction as a result of allergies and chronic obstructive pulmonary disease (COPD) is predicted to further pressure the growth of this marketplace within the coming years. COPD was the fourth-leading trusted source cause of death in the United States in 2016, following heart disease, cancer, and unintentional injuries.

Global Nasal Drug Delivery Market Regional analysis

North America is likely to lead the global nasal drug delivery market during the forecast duration. Additionally, the well-developed healthcare region and the presence of a big variety of medical device companies in this region increase marketplace growth. According to the Centers for Disease Control and Prevention in January 2017, 30.8 million adults have been diagnosed with sinusitis in the US. As the continual obstructive pulmonary disease is determined to be the third leading reason for demise in the United States, therefore the growing occurrence of COPD may additionally help in growing the acceptance of nasal drug delivery devices. There is likewise increasingly a person with bronchial asthma that helps to see robust growth over the forecast length. In 2018, in step with a observe published in the U.S. National Library of Medicine National Institutes of Health, the occurrence of bronchial asthma is continuously excessive in Korea, in particular among women and aged populations.

Key Development

In April 17, 2019– 3M has announced that it is manufacturing an authorized generic of PROVENTIL® HFA (albuterol sulfate) Inhalation Aerosol in the U.S., which will be distributed by Par Pharmaceutical (Par) an operating company of Endo International plc.

The objective of the report is to present a comprehensive analysis of the Global Nasal Drug Delivery Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market has been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analysed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Nasal Drug Delivery Market dynamics, structure by analysing the market segments and projects the Global Nasal Drug Delivery Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Nasal Drug Delivery Market make the report investor’s guide.

This Report Is Submitted By : Maximize Market Research Company

Customization of the report:

Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.




About Maximize Market Research:

Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.

Contact info:

Name: Lumawant Godage

Organization Address: MAXIMIZE MARKET RESEARCH PVT. LTD.

Email: [email protected]

Address : Pune, Maharashtra 411051, India.

Contact: +919607195908
-- END ---
Share Facebook Twitter
Print Friendly and PDF DisclaimerReport Abuse
Contact Email [email protected]
Issued By mmr
Phone 09607365656
Business Address Omkar Heights,
Sinhagad Road,
Country India
Categories Business
Tags global nasal drug delivery market
Last Updated August 19, 2020